Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05333263
Other study ID # 20-007581
Secondary ID W81XWH-20-C-0104
Status Recruiting
Phase N/A
First received
Last updated
Start date June 17, 2022
Est. completion date October 2024

Study information

Verified date May 2024
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the accuracy with which a microprocessor-controlled treadmill delivers controlled postural disturbances.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date October 2024
Est. primary completion date October 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Healthy adults with no medical conditions or previous injuries, trauma, or surgeries that reduce your balance, mobility or strength. - Able to follow simple directions. - Willingness to participate in the study. - No restriction will be placed on gender, race, or ethnicity. Exclusion Criteria: - Current or chronic pain in your shoulders, elbows, hips, knees, ankles, feet, neck or back. - Use of assistive device such as walker or cane.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Treadmetrix
Programmable treadmill that delivers controlled postural disturbances

Locations

Country Name City State
United States Mayo Clinic Rochester Rochester Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Estimate the limits of agreement between observed and commanded treadmill belt disturbance parameters: belt displacement. Treadmill belt displacement (m) will be measured with a Motion Capture system for each perturbation trial and compared to the commanded magnitude to assess system accuracy. Duration of participant test session (approximately 2 hours)
Primary Estimate the limits of agreement between observed and commanded treadmill belt disturbance parameters: peak velocity. Treadmill belt peak velocity (m/s) will be measured with a Motion Capture system for each perturbation trial and compared to the commanded magnitude to assess system accuracy. Duration of participant test session (approximately 2 hours)
Primary Estimate the limits of agreement between observed and commanded treadmill belt disturbance parameters: average initial acceleration. Treadmill belt average initial acceleration (m/s/s) will be measured with a Motion Capture system for each perturbation trial and compared to the commanded magnitude to assess system accuracy. Duration of participant test session (approximately 2 hours)
Secondary Kinetic loading exerted on treadmill during perturbations: treadmill force. Treadmill force (N) time series will be measured with force plates imbedded in the treadmill deck and recorded for each perturbation trial to assess the mechanical loading condition on the machine. Duration of participant test session (approximately 2 hours)
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1